In den Warenkorb
Bestellen Sie auch über:
+33 (0)1 76 63 32 65
+33 (0)1 74 18 08 22

IL-17 Antikörper (Biotin)

Antigen

IL-17

Klonalität Monoklonal (TC11-8H4)
Wirt
Alternativen

Ratte

Reaktivität
Konjugat
Alternativen Biotin
Applikation
Alternativen ELISA (Detektionsantikörper), ELISPOT (Detektionsantikörper)
10 Publikationen vorhanden
Produktnummer ABIN160513
Menge 500 µg  (Varianten)
Preis Produkt für diese Region nicht verfügbar.
Lieferung nach

Produktbeschreibung

Immunogen E. coli-expressed, recombinant mouse IL-17
Isotyp IgG1, kappa chain
Klon TC11-8H4
Beschreibung Secretion of IL-6, IL-8, G-CSF, prostaglandin E2 by epithelial, endothelial or fibroblastic cells, stimulates cell migration, cord formation, and IL-6 secretion by stromal cells CD4 memory T cells IL-17, also known as CTLA-8, is a T cell-expressed pleiotropic cytokine that exhibits a high degree of homology to a protein encoded by the ORF13 gene of herpes virus Saimiri. Recent study has shown that IL-17 is produced by Th cells (Th17) that are distinct from the traditional Th1- and Th2-cell subsets. IL-23 plays an important role in triggering IL-17 production. Both recombinant and natural IL-17 have been shown to exist as disulfide linked homodimers. IL-17 exhibits multiple biological activities on a variety of cells including: the induction of IL-6 and IL-8 production in fibroblasts, activation of NF-kappaB and costimulation of T cell proliferation. IL-17 is an essential inflammatory mediator in the development of autoimmune diseases. Neutralization of IL-17 with monoclonal antibody is able to ameliorate the disease course. The TC11-8H4 antibody antibody reacts with mouse interleukin-17 (IL-17). Synonyms: Interleukin-17, Cytotoxic T lymphocyte-associated antigen 8 (CTLA-8) Structure: Cytokine, dimer, 15 kD (Mammalian)

Anwendungen

Applikationshinweise ELISA and ELISPOT Detection: The biotinylated TC11-8H4 antibody is useful as a detection antibody for a sandwich ELISA assay, when used in conjunction with purified TC11-18H10 antibody (ABIN160496) as the capture antibody, and with recombinant mouse IL-17 (ABIN160666) as the standard. Additional reported applications (for the relevant formats) include: Western blotting. Each lot of this antibody is quality control tested by ELISA assay. For use as an ELISA detection antibody, a concentration range of 0.5-2 µg/ml is recommended. To obtain a linear standard curve, serial dilutions of IL-17 recombinant protein ranging from 4000 to 30 pg/ml are recommended for each ELISA plate. It is recommended that the reagent be titrated for optimal performance for each application.
Reinigung The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions. The solution is free of unconjugated biotin.
Buffer Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Lagerung The antibody solution should be stored undiluted at 4°C. Do not freeze.
Forschungsgebiet Zytokine, Immunologie, Virologie, Inflammation, Krebs
Beschränkungen Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen Fossiez, Djossou, Chomarat et al.: "T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines." in: The Journal of experimental medicine, Vol. 183, Issue 6, pp. 2593-603, 1996 (PubMed).

Kennedy, Rossi, Zurawski et al.: "Mouse IL-17: a cytokine preferentially expressed by alpha beta TCR + CD4-CD8-T cells." in: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, Vol. 16, Issue 8, pp. 611-7, 1997 (PubMed).

Yao, Spriggs, Derry et al.: "Molecular characterization of the human interleukin (IL)-17 receptor." in: Cytokine, Vol. 9, Issue 11, pp. 794-800, 1998 (PubMed).

Schwarzenberger, La Russa, Miller et al.: "IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 161, Issue 11, pp. 6383-9, 1998 (PubMed).

Infante-Duarte, Horton, Byrne et al.: "Microbial lipopeptides induce the production of IL-17 in Th cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 11, pp. 6107-15, 2000 (PubMed).

Numasaki, Fukushi, Ono et al.: "Interleukin-17 promotes angiogenesis and tumor growth." in: Blood, Vol. 101, Issue 7, pp. 2620-7, 2003 (PubMed).

Nekrasova, Shive, Gao et al.: "ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 175, Issue 4, pp. 2374-80, 2005 (PubMed).

Harrington, Hatton, Mangan et al.: "Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages." in: Nature immunology, Vol. 6, Issue 11, pp. 1123-32, 2005 (PubMed).

Hofstetter, Ibrahim, Koczan et al.: "Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis." in: Cellular immunology, Vol. 237, Issue 2, pp. 123-30, 2006 (PubMed).

Dong: "Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells." in: Nature reviews. Immunology, Vol. 6, Issue 4, pp. 329-33, 2006 (PubMed).